Erste Asset Management Gmb H Charles River Laboratories International, Inc. Transaction History

Erste Asset Management Gmb H

7 transactions

Quarter	Operation	Price Per share	shares change
Q2 2022 Nov 26, 2024	SELL	$204.13 - $302.4 $0 - $0	0 Closed
Q1 2020 Nov 22, 2024	SELL	$98.9 - $178.34 $0 - $0	0 Closed
Q4 2019 Nov 22, 2024	BUY	$126.05 - $152.76 $0 - $0	0 New
Q3 2019 Nov 22, 2024	BUY	$125.07 - $143.67 $0 - $0	0 New
Q2 2019 Nov 22, 2024	BUY	$123.4 - $148.55 $0 - $0	0 New
Q1 2019 Nov 22, 2024	BUY	$104.82 - $146.73 $0 - $0	0 New
Q4 2018 Nov 26, 2024	BUY	$105.09 - $137.23 $0 - $0	0 New

696

52.3M

259K

463K

Ticker CRL
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 50,863,300
Market Cap $10.1B
Description
Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...

Get notified when there are updates to the investment portfolio of Erste Asset Management Gmb H, based on Form 13F filings with the SEC.

Stay updated on Erste Asset Management Gmb H with notifications on news.